Viewing Study NCT06225856


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-05-25 @ 6:08 AM
Study NCT ID: NCT06225856
Status: RECRUITING
Last Update Posted: 2024-01-31
First Post: 2024-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
Sponsor: Shanghai Yuyao Biotech Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Hematological Malignancy View
Keywords: